May 10, 2018 / 11:12 AM / 6 months ago

BRIEF-Voyager Therapeutics Rpeorts Q1 GAAP Loss Per Share Of $0.63

May 10 (Reuters) - Voyager Therapeutics Inc:

* VOYAGER THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

* Q1 GAAP LOSS PER SHARE $0.63

* Q1 EARNINGS PER SHARE VIEW $-0.11 -- THOMSON REUTERS I/B/E/S

* CASH, CASH EQUIVALENTS, AND MARKETABLE DEBT SECURITIES AS OF MARCH 31, 2018 WERE $218.2 MILLION

* VOYAGER THERAPEUTICS - CONTINUES TO EXPECT TO END 2018 WITH TOTAL CASH, CASH EQUIVALENTS, MARKETABLE DEBT SECURITIES OF ABOUT $125 MILLION TO $135 MILLION

* VOYAGER THERAPEUTICS - PROJECTS TO CURRENTLY BE ABLE TO FUND OPERATING EXPENSES, CAPEX REQUIREMENTS INTO EARLY 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below